Trial Comparing Stereotactic Body Radiation Therapy to Radiofrequency Ablation for Renal Cell Carcinoma

Stopped early · Not applicable

Conditions studied: Renal Cell Carcinoma

In brief

This study will assess whether Stereotactic Body Radiation Therapy (SBRT) can provide comparable local control, with similar or improved toxicity rates compared to Radio Frequency Ablation (RFA) when treating small renal cell carcinomas.

Key facts

Study ID

NCT02138578

Run by

University of Michigan Rogel Cancer Center

People needed

4

Starts

2014-05-01

Expected to finish

2017-02-01

Last updated by the study team

2017-11-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may not qualify if…

• Patients younger than 18 or pregnant women.

Where it is running

• University of Michigan Hospital — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.